170 related articles for article (PubMed ID: 15473404)
21. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
22. Managing hot flashes in men being treated for prostate cancer.
Baum NH; Torti DC
Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of core and surface body temperatures, prevalence, onset, duration and severity of hot flashes in men after bilateral orchidectomy for prostate cancer.
Aziz NA; Heyns CF
Int Braz J Urol; 2008; 34(1):15-20; discussion 20-2. PubMed ID: 18341717
[TBL] [Abstract][Full Text] [Related]
24. Treatment of menopausal hot flashes.
Tong IL
Med Health R I; 2008 Mar; 91(3):73-6. PubMed ID: 18438096
[No Abstract] [Full Text] [Related]
25. Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.
Gonzalez BD; Jim HS; Donovan KA; Small BJ; Sutton SK; Park J; Lin HY; Spiess PE; Fishman MN; Jacobsen PB
J Urol; 2015 Sep; 194(3):690-5. PubMed ID: 25791402
[TBL] [Abstract][Full Text] [Related]
26. Pilot evaluation of citalopram for the relief of hot flashes.
Barton DL; Loprinzi CL; Novotny P; Shanafelt T; Sloan J; Wahner-Roedler D; Rummans TA; Christensen B; Dakhill SR; Martin LS
J Support Oncol; 2003; 1(1):47-51. PubMed ID: 15352642
[TBL] [Abstract][Full Text] [Related]
27. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation.
Soares CN; Joffe H; Viguera AC; Petrillo L; Rydzewski M; Yehezkel R; Somley B; Cohen LS
Am J Med; 2008 Feb; 121(2):159-162.e1. PubMed ID: 18261506
[TBL] [Abstract][Full Text] [Related]
28. The Relationship between Hot Flashes and Testosterone Recovery after 12 Months of Androgen Suppression for Men with Localised Prostate Cancer in the ASCENDE-RT Trial.
Dosani M; Morris WJ; Tyldesley S; Pickles T
Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):696-701. PubMed ID: 28712786
[TBL] [Abstract][Full Text] [Related]
29. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
30. Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer.
Langenstroer P; Kramer B; Cutting B; Amling C; Poultan T; Lance R; Thrasher JB
J Urol; 2005 Aug; 174(2):642-5. PubMed ID: 16006929
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation.
Vandecasteele K; Ost P; Oosterlinck W; Fonteyne V; Neve WD; Meerleer GD
Phytother Res; 2012 Feb; 26(2):208-13. PubMed ID: 21630361
[TBL] [Abstract][Full Text] [Related]
32. Acupuncture for hot flashes in patients with prostate cancer.
Beer TM; Benavides M; Emmons SL; Hayes M; Liu G; Garzotto M; Donovan D; Katovic N; Reeder C; Eilers K
Urology; 2010 Nov; 76(5):1182-8. PubMed ID: 20494414
[TBL] [Abstract][Full Text] [Related]
33. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
34. [The clinical efficacy of SNRI milnacipran in the treatment of hot flushes with prostate cancer hormonally treated].
Suzuki H; Komiya A; Kojima S; Tobe T; Ueda T; Ichikawa T
Hinyokika Kiyo; 2007 Jun; 53(6):375-9. PubMed ID: 17628934
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis.
Bardia A; Novotny P; Sloan J; Barton D; Loprinzi C
Menopause; 2009; 16(3):477-83. PubMed ID: 19188850
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hot flushes in breast and prostate cancer.
Adelson KB; Loprinzi CL; Hershman DL
Expert Opin Pharmacother; 2005 Jun; 6(7):1095-106. PubMed ID: 15957964
[TBL] [Abstract][Full Text] [Related]
37. Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study.
Mariani L; Quattrini M; Atlante M; Galati M; Barbati A; Giannarelli D
J Exp Clin Cancer Res; 2005 Sep; 24(3):373-8. PubMed ID: 16270523
[TBL] [Abstract][Full Text] [Related]
38. [A clinical study of estramustine phosphate sodium for the treatment of hot flushes in men with prostate cancer].
Fukuhara S; Yokoyama S; Tsutahara K; Mori N; Hara T; Yamaguchi S
Nihon Hinyokika Gakkai Zasshi; 2004 Sep; 95(6):761-5. PubMed ID: 15508700
[TBL] [Abstract][Full Text] [Related]
39. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
